Agios Pharmaceuticals (AGIO) Operating Income (QoQ) (2012 - 2026)

Agios Pharmaceuticals (AGIO) Operating Income (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Agios Pharmaceuticals 2.13 Bn 2.13 Bn 19.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.50%
Dec 31, 2025 -4.03%
Sep 30, 2025 8.02%
Jun 30, 2025 -19.16%
Mar 31, 2025 14.72%
Dec 31, 2024 -21.62%
Sep 30, 2024 2.84%
Jun 30, 2024 -14.93%
Mar 31, 2024 13.37%
Dec 31, 2023 -5.33%
Sep 30, 2023 -7.68%
Jun 30, 2023 -3.41%
Mar 31, 2023 8.63%
Dec 31, 2022 -8.87%
Sep 30, 2022 6.71%
Jun 30, 2022 3.47%
Mar 31, 2022 3.51%
Dec 31, 2021 -15.00%
Sep 30, 2021 0.08%
Jun 30, 2021 -0.01%